(FY)Jun 30, 2023 | (FY)Jun 30, 2022 | |
---|---|---|
Operating cash flow (direct method) | ||
Cash income from operating activities | ||
Cash paid | -121.73%-1.09M | -490.61K |
Payments to suppliers for goods and services | -121.73%-1.09M | ---490.61K |
Direct interest received | 25,100.44%115.67K | --459 |
Operating cash flow | -98.34%-972.14K | ---490.15K |
Investing cash flow | ||
Cash flow from continuing investing activities | -434.59%-3.52M | -658.91K |
Capital expenditure reported | -596.93%-3.44M | ---493.99K |
Net PPE purchase and sale | 51.68%-79.7K | ---164.92K |
Cash from discontinued investing activities | ||
Investing cash flow | -434.59%-3.52M | ---658.91K |
Financing cash flow | ||
Cash flow from continuing financing activities | -103.65%-347K | 9.51M |
Net issuance payments of debt | ---- | ---304.7K |
Net common stock issuance | -103.54%-347K | --9.81M |
Cash from discontinued financing activities | ||
Financing cash flow | -103.65%-347K | --9.51M |
Net cash flow | ||
Beginning cash position | --8.36M | ---- |
Current changes in cash | -157.93%-4.84M | --8.36M |
End cash Position | -57.93%3.52M | --8.36M |
Free cash from | -291.15%-4.49M | ---1.15M |
Accounting Standards | US-GAAP | US-GAAP |
No Data